Question 1

What are the potential side effects of SAR407899A?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment clinical trial (NCT01485900). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment clinical trial (NCT01485900). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the study visits involve, and how often will I need to come in?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment clinical trial (NCT01485900). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my kidney function be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment clinical trial (NCT01485900). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I do if I experience any side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment clinical trial (NCT01485900). Contact the study team or your healthcare provider for specific answers.

What this study is about